Wealthfront Advisers’s Guardant Health GH Stock Holding History

Wealthfront Advisers’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$458K	Buy	3,051 +9	+0.3%	+$979	﹤0.01%	894
2026 Q1	$281K	Buy	3,042 +204	+7%	+$20.5K	﹤0.01%	953
2025 Q4	$290K	Buy	+2,838	New	+$254K	﹤0.01%	931

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Wealthfront Advisers's GH Position: Q2 2026 in Review

Wealthfront Advisers increased its Guardant Health (GH) stake by 0.3% in Q2 2026, buying an estimated $979 and bringing the position to 3,051 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #894.

Wealthfront Advisers first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Wealthfront Advisers held 3,051 shares of Guardant Health worth $458K as of Q2 2026.
Wealthfront Advisers bought 9 Guardant Health shares in Q2 2026, an estimated $979.
Guardant Health made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #894 holding.
Wealthfront Advisers first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.